Share on LinkedInShare on LinkedIn

ARTICLE · 20 MAY 2026

AI And Life Sciences IP: A Practical And Evolving Guide For In-House Counsel’s AI Use

The life sciences industry sits at the intersection of extraordinary innovation and complexity.

United StatesIntellectual Property

The life sciences industry sits at the intersection of extraordinary innovation and complexity. Protecting life sciences inventions encompassing novel biologics, small-molecule therapeutics, medical devices, and diagnostic tools demands a level of precision, speed, and strategic foresight that traditional IP workflows struggle to deliver. Artificial intelligence (AI) is changing that equation. In-house attorneys and/or their outside counsel partners who understand how to deploy AI effectively and strategically are gaining a meaningful market edge.

Life sciences inventions present IP challenges that few other industries share. Patent claims must navigate dense regulatory landscapes, complex prior art spanning multiple scientific disciplines, and narrow windows of exclusivity that can make or break a product's commercial viability. Prosecution timelines often run in parallel with clinical development, FDA review, and competitive threats from biosimilar and generic competitors. The

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from